UBS Group’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,900
| Closed | -$7.11K | – | 9061 |
|
|
2024
Q1 | $7.11K | Buy |
4,900
+4,010
| +451% | +$5.82K | ﹤0.01% | 6240 |
|
|
2023
Q4 | $67 | Buy |
+890
| New | +$67 | ﹤0.01% | 7745 |
|
|
2023
Q1 | – | Sell |
-1,300
| Closed | -$65 | – | 9406 |
|
|
2022
Q4 | $65 | Sell |
1,300
-501
| -28% | -$25 | ﹤0.01% | 9252 |
|
|
2022
Q3 | $0 | Hold |
1,801
| – | – | ﹤0.01% | 9948 |
|
|
2022
Q2 | $0 | Hold |
1,801
| – | – | ﹤0.01% | 9975 |
|
|
2022
Q1 | $1K | Hold |
1,801
| – | – | ﹤0.01% | 8927 |
|
|
2021
Q4 | $1K | Sell |
1,801
-899
| -33% | -$499 | ﹤0.01% | 8941 |
|
|
2021
Q3 | $2K | Hold |
2,700
| – | – | ﹤0.01% | 7865 |
|
|
2021
Q2 | $3K | Buy |
+2,700
| New | +$3K | ﹤0.01% | 7750 |
|